World's Best Scientists 2026 revealed!
Phytomedicine
H-index 49

Phytomedicine

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 214 139 209 33
Medicine 560 48 137 33

Additional Metrics

Number of Best Scientists*: 509
Documents by Best Scientists*: 695
Top 100 Ranked Scientists*: 11
SCIMAGO H-index: 150
SCIMAGO SJR: 1.694
Impact Factor: 8.3

Overview

Top Research Topics at Phytomedicine?

The discussions in Phytomedicine mainly cover the fields of Pharmacology, Internal medicine, Biochemistry, Traditional medicine and Endocrinology. Phytomedicine addresses concerns in Pharmacology which are intertwined with other disciplines, such as Oxidative stress, Inflammation, Apoptosis, Phytotherapy and In vivo. Some problems in Apoptosis that were presented in Phytomedicine overlapped with concepts under Cancer cell, Molecular biology and Cell culture.

Phytomedicine connects research in Cancer cell with the related topic of Cancer research. Phytomedicine links adjacent topics like Cancer research with Cell growth. Discussions in it are anchored in the subject of In vivo and the similar topic of In vitro.

Diabetes mellitus, Placebo and Gastroenterology are some topics wherein Internal medicine research discussed in the journal have an impact. The presentations discussing Biochemistry offer insights in topics such as Antioxidant, Lipid peroxidation and Glutathione. The in-depth study on Traditional medicine also explores topics in the intersecting field of Botany.

  • Pharmacology (35.16%)
  • Internal medicine (16.74%)
  • Biochemistry (16.21%)

What are the most cited papers published in the journal?

  • Antidiabetic plants and their active constituents. (859 citations)
  • Synergy research: approaching a new generation of phytopharmaceuticals. (810 citations)
  • Synergy and other interactions in phytomedicines. (659 citations)

Research areas of the most cited articles at Phytomedicine:

The most cited papers tackle a plethora of topics, such as Pharmacology, Biochemistry, Traditional medicine, Internal medicine and Phytotherapy. The majority of Pharmacology studies presented in the published articles zero in on Oral administration. In addition to Internal medicine research, the most cited publications aim to explore topics under Gastroenterology and Endocrinology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Botany
  • Enzyme

The previous edition focused in particular on these issues:

The journal explores disciplines such as Pharmacology, Cancer research, In vivo, Apoptosis and Inflammation. The study of PI3K/AKT/mTOR pathway and how it intertwines with concepts under Autophagy were explored in the presented Pharmacology research. Issues in Cancer research were discussed, taking into consideration concepts from other disciplines like Cancer, Cytotoxic T cell, MTT assay, Cell growth and Viability assay.

It holds forums on In vivo that merges themes from other disciplines such as In vitro and Western blot. Apoptosis research presented in the journal encompasses a variety of subjects, including Cell culture, Reactive oxygen species and Cell. Inflammation and Tumor necrosis factor alpha are closely related fields of research discussed in the journal.

The most cited articles from the last journal are:

  • Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial. (151 citations)
  • Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. (44 citations)
  • Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review. (37 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Phytomedicine (based on the number of publications) are:

  • Thomas Efferth (82 papers) published 13 papers at the last edition, 8 more than at the previous edition,
  • Hildebert Wagner (65 papers) absent at the last edition,
  • Alexander Panossian (39 papers) absent at the last edition,
  • Michael Wink (35 papers) absent at the last edition,
  • Olaf Kelber (22 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Phytomedicine (based on the number of publications) are:

  • Peking Union Medical College (114 papers) published 31 papers at the last edition, 24 more than at the previous edition,
  • China Pharmaceutical University (94 papers) published 14 papers at the last edition, 4 more than at the previous edition,
  • The Chinese University of Hong Kong (84 papers) published 4 papers at the last edition, 2 more than at the previous edition,
  • University of Mainz (82 papers) published 13 papers at the last edition, 9 more than at the previous edition,
  • Ludwig Maximilian University of Munich (78 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.77% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 28.07% were posted by at least one author from the top 10 institutions publishing in the journal. Another 8.33% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 23.03% of all publications and 40.57% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.

    Ke Hu;Wei-jie Guan;Ying Bi;Wei Zhang

    (2021)
    453 Citations
  • Herbal Immune-boosters: Substantial Warriors of Pandemic Covid-19 Battle

    Kanika Khanna;Sukhmeen Kaur Kohli;Ravdeep Kaur;Abhay Bhardwaj

    (2021)
    172 Citations
  • Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis

    David Y.W. Lee;Qing Y. Li;Jing Liu;Thomas Efferth

    (2021)
    154 Citations
  • Glycyrrhizic acid exerts inhibitory activity against the spike protein of SARS-CoV-2

    Unknown

    (2020)
    146 Citations
  • Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.

    Jing Zhao;Saisai Tian;Dong Lu;Jian Yang

    (2021)
    121 Citations
  • Dietary polyphenols in chemoprevention and synergistic effect in cancer: Clinical evidences and molecular mechanisms of action.

    Srimanta Patra;Biswajita Pradhan;Rabindra Nayak;Chhandashree Behera

    (2021)
    112 Citations
  • Analytical strategies for the discovery and validation of quality-markers of traditional Chinese medicine.

    Jun-ling Ren;Ai-Hua Zhang;Ling Kong;Ying Han

    (2020)
    91 Citations
  • Therapeutic potential of hesperidin and its aglycone hesperetin: Cell cycle regulation and apoptosis induction in cancer models.

    José Miguel P. Ferreira de Oliveira;Conceição Santos;Eduarda Fernandes

    (2020)
    87 Citations
  • Quercetin- and rutin-based nano-formulations for cancer treatment: A systematic review of improved efficacy and molecular mechanisms.

    (2021)
    87 Citations
  • The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis.

    (2022)
    84 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but unsure about pursuing a full medical degree, there are several related online degree options worth considering. Medical billing and coding, for instance, is a growing field that supports healthcare administration. Understanding the medical coding certification cost can help prospective students plan their educational investment effectively.

Another accessible route into the healthcare field is through nursing. Many students seek a nursing school with high acceptance rate to ensure their chances of admission remain strong while preparing for rewarding careers as registered nurses or nurse practitioners.

For those interested in the managerial side of healthcare, pursuing an accelerated healthcare administration degree online offers a fast track to leadership roles. Alternatively, exploring various healthcare administration degrees can provide insight into affordable programs that balance cost with quality education, making it easier to step into administrative positions in hospitals, clinics, or insurance companies.

Overall, these pathways provide valuable alternatives or complements to traditional medical studies, each catering to different interests and career goals within the vast healthcare industry.

Best Scientists Contributing to This Journal

Recently Published Articles